Physician Assistant in Fallon, NV Accepting Medicare

9 Physician Assistant nurses found. Showing 1 - 9

Arron Stokes, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 4755 Pasture Rd, Fallon, NV 89496 Phone: 775-426-3125

Jesus Ricardo Martinez, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4755 Pasture Rd Bldg 299, Fallon, NV 89496 Phone: 775-426-3125

Sharon Lynn Maxwell, PA-C, MPAS Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 E Williams Ave, Fallon, NV 89406 Phone: 775-423-3151    Fax: 775-423-9366

Kimberly Jean Radai, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1020 New River Pkwy Ste 200, Fallon, NV 89406 Phone: 775-428-2633    Fax: 775-428-2630

Christa Robinson, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 801 E Williams Ave, Fallon, NV 89406 Phone: 775-867-7740

Vivian L Graham, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1020 New River Pkwy Ste 200, Fallon, NV 89406 Phone: 775-428-2150    Fax: 775-428-2151

Daniel Matthew Stasik, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 E Williams Ave, Fallon, NV 89406 Phone: 775-867-7740    Fax: 775-423-4219

Heather Laree Sartain, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 801 E Williams Ave, Fallon, NV 89406 Phone: 775-867-7757

Matthew Gregory West, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 E Williams Ave Ste 2207, Fallon, NV 89406 Phone: 775-423-3151    Fax: 775-428-2166

News Archive

ETI develops extended release SC depot formulation of NSAID drug meloxicam

Encore Therapeutics Inc. has developed a proprietary extended release subcutaneous (SC) depot formulation (ETI-511) of the NSAID drug meloxicam.

Cancer patients in Southern Italy have higher concentration of toxic metals in their blood

Toxic environmental agents, to which anyone is involuntarily exposed, represent non-negligible risk for human health and, therefore, environmental contamination has become a theme of primary importance worldwide.

Entasis and GARDP partner to develop oral antibiotic for treatment of drug-resistant gonorrhea

Zoliflodacin, a novel first-in-class oral antibiotic and one of the only treatments in development to address the rapidly-growing threat of drug-resistant gonorrhea will enter pivotal trials, thanks to a new partnership between the not-for-profit Global Antibiotic Research and Development Partnership and Entasis Therapeutics.

Cold Spring Harbor Laboratory Press releases new book on cancer evolution

Cold Spring Harbor Laboratory Press announced the release of Cancer Evolution, available on its website in hardcover and ebook formats.

New HPLC-Chip introduced to address N-glycan analysis in biopharmaceutical market

Agilent Technologies Inc. today introduced a new HPLC-Chip to address N-glycan analysis in the emerging biopharmaceutical market.

Read more Medical News

› Verified 4 days ago